Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

Regeneron: It’s the Eylea Outlook That Matters
Barron's
Mon, 02/8/16 - 12:46 pm
Tags:
Regeneron, Eylea
3 Things to Look for in Regeneron Pharmaceuticals Inc.'s Earnings
Motley Fool
Fri, 02/5/16 - 09:37 pm
Tags:
Regeneron, earnings
How Amgen may Impact Regeneron Q4 Earnings
Bidness, ETC
Thu, 02/4/16 - 06:33 pm
Tags:
Amgen, Regeneron, earnings
Will Regeneron’s Earnings Continue to Impress Investors?
Yahoo/Market Realist
Wed, 01/27/16 - 04:10 pm
Tags:
earnings, Regeneron
Sanofi and Regeneron likely to cough up royalties to end Amgen's PCSK9 patent suit: Analyst
Fierce Pharma
Tue, 01/26/16 - 09:03 pm
Tags:
Sanofi, Regeneron, Amgen, PCSK9 inhibitors, patents, Repatha, Praluent
Will 2016 Be Regeneron Pharmaceuticals Inc.'s Best Year Yet?
Motley Fool
Wed, 01/6/16 - 03:11 pm
Tags:
Regeneron, Praluent, Eylea
Feuerstein's Heroes and Zeroes of Biotech Investing in 2015
Yahoo/TheStreet.com
Mon, 01/4/16 - 09:20 am
Tags:
biotech, Sprout Pharmaceuticals, Addyi, Novartis, Entresto, Hillary Clinton, Regeneron, Biogen, CAR-T, Valeant Pharmaceuticals, gene therapy, Theranos, Incyte, Afrezza
What Does 2016 Hold for Biotech Stocks?
Motley Fool
Sun, 01/3/16 - 10:27 pm
Tags:
biotech, Gilead Sciences, Celgene, Amgen, Regeneron, Sanofi, Biomarin, Sarepta Th
How Gilead Sciences M&A Can Pan Out Next Year
Bidness, ETC
Tue, 12/29/15 - 09:36 am
Tags:
Gilead Sciences, M&A, Vertex Pharmaceuticals, Incyte, Biomarin, Regeneron
The Worst Regeneron Pharmaceuticals, Inc. Headlines in 2015
Motley Fool
Sat, 12/26/15 - 11:58 am
Tags:
Regeneron
Amgen PCSK-9 Prescription Volumes Ahead of Regeneron Pharmaceuticals
Bidness, ETC
Fri, 12/18/15 - 09:09 am
Tags:
Amgen, PCSK9 inhibitors, Regeneron, Sanofi, Repatha, Praluent
Latest cholesterol drug comes with a $14,600-a-year price tag
Marketwatch
Mon, 12/14/15 - 04:27 pm
Tags:
cholesterol, Praluent, Regeneron, Sanofi
This May Be The Fastest-Growing Biotech Stock Next Year (Hint: It's Not Gilead Sciences)
Motley Fool
Mon, 12/14/15 - 10:07 am
Tags:
Gilead Sciences, Regeneron
The new PCSK9 scorecard: Praluent favored by UnitedHealth, Repatha by CVS, both by Express Scripts
BioPharma Dive
Fri, 12/11/15 - 10:23 pm
Tags:
PCSK9 inhibitors, Praluent, Repatha, Regeneron, Sanofi, Amgen, Unitedhealth Group, CVS, Express Scripts
Amgen and Regeneron Face Declining PCSK-9 Prescription Volumes
Bidness, ETC
Mon, 12/7/15 - 03:02 pm
Tags:
Amgen, Regeneron, PCSK9 inhibitors, Sanofi, Praluent, Repatha
Repatha Vs. Praluent: Will Amgen's Patents Decide The Race For The Prevailing PCSK9 Inhibitor?
Seeking Alpha
Wed, 12/2/15 - 09:27 am
Tags:
Repatha, Praluent, Amgen, Sanofi, Regeneron, PCSK9 inhibitors, patents
UnitedHealth Unit Favors Sanofi, Regeneron Cholesterol Drug
Bloomberg
Tue, 12/1/15 - 10:16 am
Tags:
Unitedhealth Group, Sanofi, Regeneron, Amgen, Praluent, Repatha
Sanofi, Regeneron prepped PCSK9 rollout with 'Cholesterol Counts' campaign
Fierce Pharma Marketing
Mon, 11/30/15 - 06:51 pm
Tags:
Sanofi, Regeneron, PCSK9 inhibitors, Praluent
CVS Chooses Repatha as New Cholesterol Drug for Caremark
WSJ Online
Mon, 11/23/15 - 09:35 am
Tags:
CVS Caremark, Amgen, Repatha, Sanofi, Regeneron, Praluent
Biotechs Go Low-Fat: Relevance To Amgen, Regeneron, The Medicines Company And Isis
Seeking Alpha
Thu, 11/19/15 - 04:39 pm
Tags:
Amgen, Regeneron, Medicines Company, Isis Pharmaceuticals, Gilead Sciences, Biogen

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.